STOCK TITAN
  1. Home
  2. SMFRW

SMFRW Stock Price, News & Analysis

SMFRW

Company Description

SMFRW (Nasdaq: SMFRW) is a publicly traded company.

SMFRW stock has declined 96.9% over the past year.

This page provides a comprehensive overview of SMFRW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-96.86%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

SMFRW (SMFRW) stock. Over the past 12 months, the stock has lost 96.9%.

Latest News

View All
0.00%

Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance

earnings
+11.76%

Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference

conferences
+2.67%

New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU

-28.00%

Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction

earnings
+1.16%

Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022

conferences earnings
-4.70%

Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies

SMFRW has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, conferences, clinical trial. View all SMFRW news →

SEC Filings

View All

No SEC filings available for SMFRW.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months